| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Fibro-Vein 3% (150 mg/5 mL) injection, 5 mL vial | has Australian BoSS | True | sodium tetradecyl sulfate | Inferred relationship | Some | 2139626818 | 
| sodium tetradecyl sulfate | has intended active ingredient | True | sodium tetradecyl sulfate | Inferred relationship | Some | 1 | 
| sodium tetradecyl sulfate 0.5% (10 mg/2 mL) injection, ampoule | has intended active ingredient | True | sodium tetradecyl sulfate | Inferred relationship | Some | 1296271454 | 
| sodium tetradecyl sulfate 0.5% (10 mg/2 mL) injection, ampoule | has Australian BoSS | True | sodium tetradecyl sulfate | Inferred relationship | Some | 1296271454 | 
| sodium tetradecyl sulfate 1% (20 mg/2 mL) injection, ampoule | has intended active ingredient | True | sodium tetradecyl sulfate | Inferred relationship | Some | 1800729918 | 
| sodium tetradecyl sulfate 1% (20 mg/2 mL) injection, ampoule | has Australian BoSS | True | sodium tetradecyl sulfate | Inferred relationship | Some | 1800729918 | 
| sodium tetradecyl sulfate 3% (60 mg/2 mL) injection, ampoule | has intended active ingredient | True | sodium tetradecyl sulfate | Inferred relationship | Some | 593416510 | 
| sodium tetradecyl sulfate 3% (60 mg/2 mL) injection, ampoule | has Australian BoSS | True | sodium tetradecyl sulfate | Inferred relationship | Some | 593416510 | 
| sodium tetradecyl sulfate 0.2% (10 mg/5 mL) injection, vial | has intended active ingredient | True | sodium tetradecyl sulfate | Inferred relationship | Some | 330546850 | 
| sodium tetradecyl sulfate 0.2% (10 mg/5 mL) injection, vial | has Australian BoSS | True | sodium tetradecyl sulfate | Inferred relationship | Some | 330546850 | 
| sodium tetradecyl sulfate 3% (150 mg/5 mL) injection, vial | has intended active ingredient | True | sodium tetradecyl sulfate | Inferred relationship | Some | 263432126 | 
| sodium tetradecyl sulfate 3% (150 mg/5 mL) injection, vial | has Australian BoSS | True | sodium tetradecyl sulfate | Inferred relationship | Some | 263432126 | 
| Fibro-Vein 0.2% (10 mg/5 mL) injection, 5 mL vial | has intended active ingredient | True | sodium tetradecyl sulfate | Inferred relationship | Some | 1239114910 | 
| Fibro-Vein 1% (20 mg/2 mL) injection, 2 mL ampoule | has intended active ingredient | True | sodium tetradecyl sulfate | Inferred relationship | Some | 404672062 | 
| Fibro-Vein 0.5% (10 mg/2 mL) injection, 2 mL ampoule | has Australian BoSS | True | sodium tetradecyl sulfate | Inferred relationship | Some | 1861499614 | 
| Fibro-Vein (sodium tetradecyl sulfate 60 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | has Australian BoSS | True | sodium tetradecyl sulfate | Inferred relationship | Some | 1735360286 | 
| Fibro-Vein 0.2% (10 mg/5 mL) injection, 5 mL vial | has Australian BoSS | True | sodium tetradecyl sulfate | Inferred relationship | Some | 1239114910 | 
| Fibro-Vein 3% (150 mg/5 mL) injection, 5 mL vial | has intended active ingredient | True | sodium tetradecyl sulfate | Inferred relationship | Some | 2139626818 | 
| Fibro-Vein 0.5% (10 mg/2 mL) injection, 2 mL ampoule | has intended active ingredient | True | sodium tetradecyl sulfate | Inferred relationship | Some | 1861499614 | 
| Fibro-Vein (sodium tetradecyl sulfate 60 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | has intended active ingredient | True | sodium tetradecyl sulfate | Inferred relationship | Some | 1735360286 | 
| Fibro-Vein 1% (20 mg/2 mL) injection, 2 mL ampoule | has Australian BoSS | True | sodium tetradecyl sulfate | Inferred relationship | Some | 404672062 |